FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281860857> ?p ?o ?g. }

• W4281860857 abstract "Ovarian cancer has the highest mortality amongst all gynaecological malignancies, with around two-thirds of patients diagnosed with advanced disease due to late presentation. Furthermore, around 90% of patients develop recurrence and eventually become chemoresistant. Therefore, there is a high demand to identify biomarkers specific to this disease for screening for early detection, as well as new therapeutic targets. Tight junctions (TJs) regulate paracellular permeability and are vital in establishing epithelial cell polarity. One hallmark of tumorigenesis is the loss of TJs, with loss of cell-to-cell adhesion. Claudins are integral TJ membrane proteins, which have been found to play a critical role in maintaining the TJ's barrier function. Furthermore, claudin-3 (CLDN3) and claudin-4 (CLDN4) are overexpressed in ovarian cancer. This article aims to explore the biological role of CLDN3 and CLDN4 and their potential in different aspects of the management of ovarian cancer.CLDN3 and CLDN4 have been shown to be effective markers for the early detection of ovarian cancer. Whilst there is difficulty in screening for both claudins in serum, their assessment by gene expression analysis and immunohistochemical methods shows promising potential as diagnostic and prognostic biomarkers for ovarian cancer. The localisation and overexpression of claudins, such as CLDN3, have been shown to correlate with poorer survival outcomes. The added value of combining claudins with other markers such as CA125 for diagnosis has also been highlighted. Therapeutically, CLDN3 and more so CLDN4 have been shown to be effective targets of Clostridium perfringens enterotoxin (CPE). Interestingly, CPE has also been shown to resensitise chemoresistant tumours to therapy.This review presents the diagnostic and prognostic potential of CLDN3 and CLDN4 and their emerging role as therapeutic targets in ovarian cancer. Clinical trials are required to validate the promising results of the in vitro and in vivo studies for CLDN3 and CLDN4, possibly adding onto current ovarian cancer management." @default.
• W4281860857 created "2022-06-13" @default.
• W4281860857 creator A5059932680 @default.
• W4281860857 creator A5071077684 @default.
• W4281860857 date "2022-06-06" @default.
• W4281860857 modified "2023-10-15" @default.
• W4281860857 title "Potential roles of claudin-3 and claudin-4 in ovarian cancer management" @default.
• W4281860857 cites W1483659760 @default.
• W4281860857 cites W1554042779 @default.
• W4281860857 cites W1968744970 @default.
• W4281860857 cites W1985541549 @default.
• W4281860857 cites W1993728532 @default.
• W4281860857 cites W2003460945 @default.
• W4281860857 cites W2036162802 @default.
• W4281860857 cites W2041455809 @default.
• W4281860857 cites W2050817655 @default.
• W4281860857 cites W2065424392 @default.
• W4281860857 cites W2080713501 @default.
• W4281860857 cites W2111927424 @default.
• W4281860857 cites W2116700374 @default.
• W4281860857 cites W2127465578 @default.
• W4281860857 cites W2129234932 @default.
• W4281860857 cites W2132244795 @default.
• W4281860857 cites W2144024213 @default.
• W4281860857 cites W2147051115 @default.
• W4281860857 cites W2154594288 @default.
• W4281860857 cites W2155890759 @default.
• W4281860857 cites W2164216532 @default.
• W4281860857 cites W2169272869 @default.
• W4281860857 cites W2254624872 @default.
• W4281860857 cites W2268043966 @default.
• W4281860857 cites W2765797716 @default.
• W4281860857 cites W2794814234 @default.
• W4281860857 cites W2894550158 @default.
• W4281860857 cites W2908398301 @default.
• W4281860857 cites W3092330504 @default.
• W4281860857 cites W3099043519 @default.
• W4281860857 cites W342611425 @default.
• W4281860857 cites W4211203170 @default.
• W4281860857 cites W4243653664 @default.
• W4281860857 doi "https://doi.org/10.1186/s43046-022-00125-4" @default.
• W4281860857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35665865" @default.
• W4281860857 hasPublicationYear "2022" @default.
• W4281860857 type Work @default.
• W4281860857 citedByCount "4" @default.
• W4281860857 countsByYear W42818608572022 @default.
• W4281860857 countsByYear W42818608572023 @default.
• W4281860857 crossrefType "journal-article" @default.
• W4281860857 hasAuthorship W4281860857A5059932680 @default.
• W4281860857 hasAuthorship W4281860857A5071077684 @default.
• W4281860857 hasBestOaLocation W42818608571 @default.
• W4281860857 hasConcept C120882062 @default.
• W4281860857 hasConcept C121608353 @default.
• W4281860857 hasConcept C126322002 @default.
• W4281860857 hasConcept C177779419 @default.
• W4281860857 hasConcept C2780427987 @default.
• W4281860857 hasConcept C41625074 @default.
• W4281860857 hasConcept C502942594 @default.
• W4281860857 hasConcept C51872919 @default.
• W4281860857 hasConcept C54355233 @default.
• W4281860857 hasConcept C555283112 @default.
• W4281860857 hasConcept C60644358 @default.
• W4281860857 hasConcept C60903277 @default.
• W4281860857 hasConcept C71924100 @default.
• W4281860857 hasConcept C86803240 @default.
• W4281860857 hasConcept C95444343 @default.
• W4281860857 hasConceptScore W4281860857C120882062 @default.
• W4281860857 hasConceptScore W4281860857C121608353 @default.
• W4281860857 hasConceptScore W4281860857C126322002 @default.
• W4281860857 hasConceptScore W4281860857C177779419 @default.
• W4281860857 hasConceptScore W4281860857C2780427987 @default.
• W4281860857 hasConceptScore W4281860857C41625074 @default.
• W4281860857 hasConceptScore W4281860857C502942594 @default.
• W4281860857 hasConceptScore W4281860857C51872919 @default.
• W4281860857 hasConceptScore W4281860857C54355233 @default.
• W4281860857 hasConceptScore W4281860857C555283112 @default.
• W4281860857 hasConceptScore W4281860857C60644358 @default.
• W4281860857 hasConceptScore W4281860857C60903277 @default.
• W4281860857 hasConceptScore W4281860857C71924100 @default.
• W4281860857 hasConceptScore W4281860857C86803240 @default.
• W4281860857 hasConceptScore W4281860857C95444343 @default.
• W4281860857 hasIssue "1" @default.
• W4281860857 hasLocation W42818608571 @default.
• W4281860857 hasLocation W42818608572 @default.
• W4281860857 hasOpenAccess W4281860857 @default.
• W4281860857 hasPrimaryLocation W42818608571 @default.
• W4281860857 hasRelatedWork W1729818254 @default.
• W4281860857 hasRelatedWork W190197617 @default.
• W4281860857 hasRelatedWork W2075536490 @default.
• W4281860857 hasRelatedWork W2094468216 @default.
• W4281860857 hasRelatedWork W2103690626 @default.
• W4281860857 hasRelatedWork W2149199388 @default.
• W4281860857 hasRelatedWork W2161141468 @default.
• W4281860857 hasRelatedWork W2313144407 @default.
• W4281860857 hasRelatedWork W2898469163 @default.
• W4281860857 hasRelatedWork W2780935698 @default.
• W4281860857 hasVolume "34" @default.
• W4281860857 isParatext "false" @default.
• W4281860857 isRetracted "false" @default.
• W4281860857 workType "article" @default.